4Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation[J]. Am J Respir Crit Care Med,2004,170: 22-48.
5Herbrecht R, Denning DW, Patterson TF, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis[J]. N Engl J Med,2002,347: 408-415.
7Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus[J]. Clin Infect Dis,2002,34: 7-14.
8Bretagne S, Marmorat-Khuong A, M Kuentz, et al. Serum Aspergillus galactomannan antigen testing by sandwich ELISA: practical use in neutropenic patients[J]. J Infect, 1997,35: 7-15.
9Walsh TJ, Shoham S, Petraitiene R, et al. Detection of galactomannan antigenemia in patients receiving piperacillintazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction[J]. J Clin Microbiol,2004,42 : 4744-4748.
10Gangneux JP, Lavarde D, Bretagne S, et al. Transient Aspergillus antigenemia: think of milk[J]. Lancet, 2002,359 : 1251.
7Andriole VT, Aspergilgillus infections: problems in diagnosis and treatment [ J ]. Infect Agents Dis, 1996,5 ( 1 ) :47-54.
8Abramson S. The air crescent sign [J]. Radiology, 2001, 218 (1): 230-232.
9Brahm H, Nikolaos S, Almyroudis S,et al. Prevention and early treatment of invasive fungal infection in patients with cancer and neutropenia and in stem cell transplant recipients in the era of newer broad spectrum antifungal agents and diagnostic ad- j uncts[J].CID, 2007,44 : 402-409.
10Auffret N, Janssen F, Chevalier P, et al. Voriconazole photosen sitivily:7 case Ann Dermatot Venereol[J]. Ann Dermatot Ve- nered, 2006,133(4):330-332.
